New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. ÌýYou can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
WELCOME BACK
PLATELET MONOAMINE-OXIDASE ACTIVITY IN SUBGROUPS OF SCHIZOPHRENIC DISORDERS
ÌÇÐÄ´«Ã½
PLATELET MONOAMINE-OXIDASE ACTIVITY IN SUBGROUPS OF SCHIZOPHRENIC DISORDERS SCHIZOPHRENIA BULLETIN Schildkraut, J. J., Orsulak, P. J., Schatzberg, A. F., HERZOG, J. M. 1980; 6 (2): 220-225Abstract
This article summarizes findings from a series of studies that examined platelet monoamine oxidase (MAO) activity in patients with nonaffective schizophrenic disorders and schizophrenia-related depressions. The findings indicate that mean platelet MAO activity was not different from control values in the subgroup of nonaffective schizophrenic disorders without auditory hallucinations (that is, the S-1 subgroup). However, mean platelet MAO activity was reduced in the subgroup of nonaffective schizophrenic disorders characterized by the presence of auditory hallucinations often occurring in conjunction with paranoid features (that is, the S-2 subgroup). Moreover, we found that mean platelet MAO activity was increased in schizophrenia-related depressions characterized by histories of chronic asocial, eccentric, or bizarre behavior.
View details for
View details for